The John Hancock Preferred Income Fund offers a 9.17% yield, blending preferred stocks and bonds for high current income. HPI's portfolio diverges from pure preferred stock funds, with over 40% in corporate bonds, impacting both yield and risk profile. The fund's distribution is mostly covered by net investment income and realized gains, but reliance on unrealized gains warrants monitoring.
John Hancock Preferred Income Fund is now rated a buy, trading at a 0.26% premium to NAV and offering a 9.7% yield. HPI's income-focused strategy leverages preferred securities and corporate bonds, with 59.94% investment-grade exposure and aggressive 38.64% leverage. Performance is poised to improve as interest rates decline, enhancing operating spreads and supporting higher valuations, especially with AI infrastructure-linked utilities exposure.
Assembly Biosciences, Inc. remains a Buy as Gilead licensed its HPI program, triggering a $35M payment and potential $330M in milestones. Phase 2 trials for both the HPI program (ABI-5366/1179) and HDV candidate ABI-6250 are expected to initiate by end of 2026, with interim catalysts ahead. ABI-6250 aims to be the first oral HDV therapy, addressing an unmet need with positive phase 1a data and a favorable safety profile supporting daily dosing.
HPI is a leveraged CEF blending preferred equity and BBB/BB corporate bonds, with high financials exposure and 38% leverage, magnifying both gains and losses. Despite a 9% distribution, a significant portion is return of capital, making the true yield closer to 7-8%, not fully supported by income. Valuation is unattractive: HPI trades at NAV with tight credit spreads and high rates, leaving little upside and heightened downside risk in a downturn.
The John Hancock Preferred Income Fund offers an 8.04% yield, but its portfolio is split between preferred stocks and corporate bonds, diverging from its stated strategy. The fund's share price has risen 24.18% over the past year, reducing its yield from 9.84% to 8.04%. The fund's net asset value has not kept up with the recent share price appreciation.
The John Hancock Preferred Income Fund offers an attractive 8.88% yield, one of the highest among preferred stock funds. The fund's current yield may not keep up with rising living costs if held in a taxable account. The fund has outperformed its benchmark indices and has a relatively stable distribution history, but its portfolio allocation and valuation should be considered.